Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.98
- Piotroski Score 6.00
- Grade Neutral
- Symbol (MEDP)
- Company Medpace Holdings, Inc.
- Price $341.98
- Changes Percentage (4.87%)
- Change $15.89
- Day Low $325.84
- Day High $342.35
- Year High $459.77
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/10/2025
- Fiscal Year End N/A
- Average Stock Price Target $415.00
- High Stock Price Target $452.00
- Low Stock Price Target $345.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $9.80
- Trailing P/E Ratio 40.94
- Forward P/E Ratio 40.94
- P/E Growth 40.94
- Net Income $282.81 M
Income Statement
Quarterly
Annual
Latest News of MEDP
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Medpace Holdings Inc (MEDP) Q3 2024 Earnings Call Highlights: Strong Revenue and Income Growth ...
August Troendle, CEO, discusses stable competitive pricing and normalized business environment. Elevated cancellations impacted bookings and backlog. Despite strong win rate, cancellations are due to ...
By Yahoo! Finance | 4 weeks ago -
MEDP Stock Price | Medpace Holdings Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Medpace Holdings, Inc. offers clinical development services to biotech, pharma, and medical device industries. Founded in 1992 by August James Troendle, it provides a range of services including clini...
By MarketWatch | 4 weeks ago -
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention?
Investors should focus on buying shares in profitable companies like Medpace Holdings, which has shown consistent earnings growth and stable margins. With impressive EPS growth and high insider owners...
By Yahoo! Finance | 1 month ago
